Lynn Purkins

Lynn Purkins is the vice president of clinical operations for Reneo Pharmaceuticals. Lynn has nearly three decades of drug development experience in large and small biotechnology companies. Before joining Reneo, Lynn was a founder and chief development officer at Ziarco Pharma, which was acquired by Novartis in 2017. Prior to Ziarco, Lynn held numerous roles at Pfizer, including clinical pharmacology, clinical operations and team leader for projects from target selection to clinical proof of concept. Her experience spans multiple therapeutic areas including dermatology, pain, respiratory and gastroenterology.

Lynn received a Ph.D. in nutrition and immunology from University of Leeds and a B.S. in dietetics from Leeds Beckett University.